Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption. Mediterr J Hematol Infect Dis [Internet]. 2021 Feb. 26 [cited 2026 Aug. 5];13(1):e2021022. Available from: https://www.mjhid.org/mjhid/article/view/4513